Redian新闻
>
是不是现在应该赶紧搞个university of phoenix的phd?
avatar
是不是现在应该赶紧搞个university of phoenix的phd?# EB23 - 劳工卡
C*X
1
死得值不值得?
avatar
w*5
2
瞄了一眼学费,master的学分可以抵一些,大概3~4w美金吧
比投资移民便宜多了, 还能抵税
avatar
z*8
3
这两个有什么关系?不要在这说风凉话,好不好?那也是一条生命,人家招你惹你了,
引得你在这发水贴!
avatar
t*o
4
西太平洋大学的还行么?
avatar
w*a
5
非常感人的一篇悼文。
By David Etchison
Feng Liu, PhD, was a father to a daughter of whom he was enormously proud, a
husband of thirty-one years, a lover of dogs and a lover of ribs, a fan of
the Tar Heels and the Steelers, and a brilliant scientist with an NIH-funded
research program and a paper that has been cited approximately 1,300 times.
Liu came to the University of North Carolina at Chapel Hill in the summer of
2005 as a research associate professor. He was a colleague and collaborator
of Leaf Huang, PhD, and was part of a team that came south from the
University of Pittsburgh to join the faculty of the UNC Eshelman School of
Pharmacy’s Division of Molecular Pharmaceutics.
The small family settled in Durham’s Hope Valley where Liu and his wife
enjoyed regular evening walks around the neighborhood. Liu indulged his love
of food—growing it, grilling it, eating it—but he always stayed thin. His
wife accepted a job at “that other school,” which inevitably led to good-
natured bickering every basketball season.
Liu’s research focused on delivering gene therapy and drugs to cells with
an emphasis on the treatment of cancer. He was the author of forty-five peer
-reviewed papers and ten book chapters and reviews, and he held four patents
. Liu’s work exploring the use of nanocrystals to treat multidrug-resistant
cancer was funded by the National Institutes of Health through 2016. He was
promoted to research professor in 2012.
He was well known for his work in developing a hydrodynamic technique for
introducing nucleic acids into animal cells—a process known as transfection
—during his doctoral studies. This methodology is used worldwide, and the
Gene Therapy article describing the breakthrough has been cited
approximately 1,300 times since it was published in 1999.
Born March 28, 1955, Liu lived much of his life in Shenyang, the capital
city of Liaoning Province and the largest city in northeastern China. He was
a middle child with an older and a younger sister. He attended Shenyang
Pharmaceutical University from 1978 to 1982. After earning a bachelor’s
degree in pharmacy, he worked as a research associate at the university
before returning to the classroom at Shenyang to pursue a master’s degree
in pharmaceutics, which he received in 1988.
Liu married and started a family in Shenyang but almost didn’t. He was so
nervous before a blind date that he suffered a panic attack and backed out
of the first meeting with the woman who would become his wife. He regrouped.
The second attempt was much more successful and led to marriage in 1983 and
the birth of a daughter in 1985 who would go on to graduate from the UNC
School of Medicine.
In 1993, Liu came to the United States as a visiting scientist at the
University of Pittsburgh. He began work on a PhD in pharmaceutics at Pitt in
1996 and earned his doctorate three years later. He then completed a
postdoctoral fellowship at the Pitt School of Pharmacy’s Center for
Pharmacogenetics and joined the center as an instructor in 2001 before being
promoted to research assistant professor in 2002. In 2004 he was the
recipient of an NIH Career Development Award.
Although he had been in the U.S. for more than twenty years, Liu retained
strong ties to China. He had served as a guest professor at Xi’an Jiaotong
University in Xi’an since 2004 and at his alma mater, Shenyang, since 2008.
If you asked him what his greatest accomplishment was, he probably wouldn’t
even think to mention that Gene Therapy paper that everyone else talks
about. Instead he might have told you that over the past five years on his
nightly walks with his wife he had found four lost dogs and successfully
returned them to their owners.
Liu is survived by his wife, who is a research analyst at Duke University,
and his daughter, who is a physician in Asheville, North Carolina.
avatar
t*o
6
认真问一下,如果想买一个phd title,哪里方便便宜?
avatar
w*a
7
悼文中的这句话,是对你最好的回答:
If you asked him what his greatest accomplishment was, he probably wouldn’t
even think to mention that Gene Therapy paper that everyone else talks
about. Instead he might have told you that over the past five years on his
nightly walks with his wife he had found four lost dogs and successfully
returned them to their owners.

【在 C*********X 的大作中提到】
: 死得值不值得?
avatar
w*5
8
嗯,西太平洋的更简单,我想复杂了。。。
反正美国也没有啥教育部认定
avatar
p*y
9
现在这个版上某些人,怎么这么缺德。这种问题也问得出来。
avatar
w*5
10
大家一起团购phd吧 XD

【在 t******o 的大作中提到】
: 认真问一下,如果想买一个phd title,哪里方便便宜?
avatar
t*6
11


【在 p********y 的大作中提到】
: 现在这个版上某些人,怎么这么缺德。这种问题也问得出来。
avatar
t*o
12
靠,我可是认真的;
西太平洋不行,名声臭了;有没有其它推荐的,有的话私信。

【在 w*****5 的大作中提到】
: 大家一起团购phd吧 XD
avatar
w*5
13
我也是认真的。。。
能花钱搞个phd立即拿卡的好事,谁不想
而且这种漏洞要赶紧钻,被烙印abuse了就晚了

【在 t******o 的大作中提到】
: 靠,我可是认真的;
: 西太平洋不行,名声臭了;有没有其它推荐的,有的话私信。

avatar
T*P
14
高干子女要镇定!凤凰大学早了去了,至少20年以上。刚才瞄了一眼,人是1976的,
估计比这里绝大部分人年龄都大。

以前有说法必须是成立10年以上的学校,肯定还会开个单子
凤凰大学有那么久了么
avatar
t*o
15
西太平洋大学名声太臭吧;
它的PHD多少钱,你知道么?

【在 w*****5 的大作中提到】
: 我也是认真的。。。
: 能花钱搞个phd立即拿卡的好事,谁不想
: 而且这种漏洞要赶紧钻,被烙印abuse了就晚了

avatar
w*c
16
估计会把野鸡大学排除在外吧
这方面真要放开了,烙印绝对是数量优势啊,一窝蜂的去花钱买个PHD
想想ICC的例子,国人和烙印比起来没啥数量优势

【在 w*****5 的大作中提到】
: 瞄了一眼学费,master的学分可以抵一些,大概3~4w美金吧
: 比投资移民便宜多了, 还能抵税

avatar
y*n
17
博士必须读5年以上。

【在 w**c 的大作中提到】
: 估计会把野鸡大学排除在外吧
: 这方面真要放开了,烙印绝对是数量优势啊,一窝蜂的去花钱买个PHD
: 想想ICC的例子,国人和烙印比起来没啥数量优势

avatar
T*P
18
不一定吧?

博士必须读5年以上。

【在 y********n 的大作中提到】
: 博士必须读5年以上。
avatar
h*n
19
楼上那些WSN你真觉得愿意读五年读么。那还不如申全奖读个好点的大学还不用花钱
都是想花3-4w买个文凭的,上上在线课程轻松搞定PHD

【在 y********n 的大作中提到】
: 博士必须读5年以上。
avatar
t*o
20
西太平洋是uncredited,而且已经close了。有没有其它选择
avatar
t*o
21
3-4万太贵了。全奖fulltime,耽误挣钱呢

【在 h****n 的大作中提到】
: 楼上那些WSN你真觉得愿意读五年读么。那还不如申全奖读个好点的大学还不用花钱
: 都是想花3-4w买个文凭的,上上在线课程轻松搞定PHD

avatar
h*n
22
很不错的deal了,也不耽误挣钱,在线网络课程甚至都不用听,考试随便考考就行了

【在 t******o 的大作中提到】
: 3-4万太贵了。全奖fulltime,耽误挣钱呢
avatar
t*o
23
3-4万太贵;用丽娟的算法,这相当于几十亿的机会成本

【在 h****n 的大作中提到】
: 很不错的deal了,也不耽误挣钱,在线网络课程甚至都不用听,考试随便考考就行了
相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。